Adalyn Hetzel had just celebrated her second birthday in the spring of 2024 when doctors at Children’s Hospital of ...
Despite such guidelines, though, the investigators said there is a lack of evidence-based or widely accepted consensus on ...
Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...
New research from Dartmouth Health and Dartmouth Cancer Center reveals a glowing molecule designed to highlight soft-tissue sarcomas during surgery, paving the way for more precise tumor removal and ...
The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...